Molecular & Cellular ProteomicsCancer BiologyPeer-reviewed journal article
A549 tumorigenic and BEAS-2B non-tumorigenic cell line derived small extracellular vesicles show distinct proteomic, N-glycoproteomic and chondroitin/dermatan sulfate profiles
Mirjam BalbisiiD, Tamás LangóiD, Virág Nikolett HorváthiD, Domonkos PáliD, Gitta SchlosseriD, Gábor KecskemétiiD, Zoltan Szabo, Kinga IlyésiD, Nikolett T. NagyiD, Otília TóthiD, Jing ZhengiD, Guinevere S. M. Lageveen‐KammeijeriD, Tamás VisnovitziD, Zoltán Varga, Beáta G. VértessyiD, Lilla TuriákiD
Abstract
Extracellular vesicles (EVs) are critical mediators of intercellular communication and hold promise as biomarkers and therapeutic targets in cancer, but their molecular alterations remain poorly understood. Protein glycosylation is a frequent post-translational modification; however, most EV studies focus only on proteomics, while mapping glycosylation changes of proteins are still underrepresented. To address this shortcoming, we analyzed the proteomic, N-glycoproteomic, and chondroitin/dermatan sulfate (CS/DS) glycosaminoglycan (GAG) profiles of small EVs (sEVs) derived from A549 lung adenocarcinoma and BEAS-2B non-tumorigenic epithelial cell lines. Principal component analysis and hierarchical clustering revealed that all three profiles are highly dependent on the origin of sEV, highlighting fundamental differences not only at the proteomic but also at the N-glycopeptide and CS/DS levels. Protein expression differences were primarily associated with the upregulation of cell cycle regulation, DNA repair, metabolism, and protein synthesis, while immune-related processes were predominantly downregulated. Proteomics revealed differential expressions of 5 CS proteoglycans, anticipating that their CS profile may also change. N-glycoproteomics highlighted a shift from complex to hybrid N-glycans in cancer sEVs, alongside a significant decrease in fucosylation. Prominent glycoproteins characterized with multiple glycosylation sites included versican, galectin-3-binding protein and laminins. The total amount of CS/DS increased 3.4-fold in cancer sEVs, while the ratio of the two monosulfated disaccharides changed 2-fold, suggesting altered sulfation mechanisms. These findings highlight the potential of N-glycoproteomics and GAG profiling to enhance biomarker discovery and EV-based cancer diagnostics. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=121 SRC="FIGDIR/small/643059v1_ufig1.gif" ALT="Figure 1"> View larger version (23K): org.highwire.dtl.DTLVardef@c2dfdeorg.highwire.dtl.DTLVardef@1f79452org.highwire.dtl.DTLVardef@12a9dbborg.highwire.dtl.DTLVardef@d992da_HPS_FORMAT_FIGEXP M_FIG C_FIG Proteomic, N-glycoproteomic and chondroitin/dermatan sulfate disaccharide profiles differ between A549 lung adenocarcinoma and BEAS-2B non-tumorigenic epithelial cell derived small extracellular vesicles.
- organism: human
- assay: proteomics
- assay: metagenomics
- research focus: cell type annotation
- approach: statistical model
- Citations
- 5
- FWCI
- 10.26
- Field percentile
- top 2%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- New proteomic signature in circulating extracellular vesicles from tumor-draining vein of lung adenocarcinomas patients
Jérémy Tricard, Stéphanie Durand, … Fabrice Lalloué·Cancer Cell InternationalPeer-reviewed·Apr 1, 2026
- Comprehensive palmitoyl-proteomic analysis identifies distinct protein signatures for large and small cancer-derived extracellular vesicles
J. Mariscal, T. Vagner, … D. Di Vizio·bioRxiv·Oct 2, 2019
- Extracellular Vesicles heterogeneity through the lens of multiomics
Taylon Felipe Silva, Elizabeth D. Hutchins, … Dolores Di Vizio·Cell Reports MedicinePeer-reviewed·Jun 6, 2025
- Extracellular Vesicles Carry Distinct Proteo-Transcriptomic Signatures That are Different from Their Cancer Cell of Origin
Tzu-Yi Chen, Edgar Gonzalez‐Kozlova, … Navneet Dogra·iSciencePeer-reviewed·Jan 1, 2021
- Proteomic Characterization of Serum Small Extracellular Vesicles in Human Breast Cancer
Ganfei Xu, Weiyi Huang, … Hongxia Wang·bioRxiv·Nov 26, 2021
- Proteomic profiling of extracellular vesicles distinguishes prostate cancer molecular subtypes
Megan Ludwig, Ali T. Arafa, … Justin M. Drake·Journal of Extracellular VesiclesPeer-reviewed·Oct 1, 2025